Avalon GloboCare Corp. (NASDAQ:ALBT) Sees Significant Growth in Short Interest

Avalon GloboCare Corp. (NASDAQ:ALBT) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 45,400 shares, a growth of 358.6% from the February 13th total of 9,900 shares. Based on an average daily trading volume, of 858,400 shares, the days-to-cover ratio is presently 0.1 days. Currently, 10.7% of the company’s stock are sold short.

Avalon GloboCare Trading Down 7.8 %

Shares of Avalon GloboCare stock opened at $4.50 on Friday. The stock has a fifty day simple moving average of $4.66 and a 200 day simple moving average of $3.83. Avalon GloboCare has a 12-month low of $2.11 and a 12-month high of $21.60. The company has a market capitalization of $4.92 million, a P/E ratio of -0.23 and a beta of -0.11.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.